Company News
Radyus Research and Dt&CRO Join Forces to Pave Way for South Korean Biotech Companies into the U.S. Market
Source: Radyus/PR Newswire ATLANTA, May 7, 2024 /PRNewswire/ — Radyus Research, a global drug development organization from Atlanta, Georgia, is excited to announce a pivotal strategic partnership with Dt&CRO, a leading South Korean contract research organization (CRO). This collaboration aims to assist South Korean biotech companies in entering the U.S. market by offering integrated services for drug development…
Read More6 Cornerstone Truths for Medtech Innovators (Researchers or Clinicians) in the Hospital Setting
By: Marty Jacobson with Paul Snyder | GCMI Source-GCMI Because clinicians have such an intimate knowledge of unmet clinical needs, hospitals are fertile ground for medtech innovations that improve value and outcomes. But bringing a technology or device to bear in clinical use, especially at any scale, works in much different, much more rigorous ways…
Read MoreAtlanta’s Biotech Scene Prepares for New Heights
Source: BioSpace A new project has capped off construction in Midtown Atlanta, providing physical real estate that experts say is sorely needed for the region’s growing biotech ecosystem, now home to more than 4,000 life science companies. The Science Square project completed the first phase of construction last week. Built by real estate developer Trammell Crow and Georgia Advanced Technology…
Read MoreAdvaMed Statement on the Release of FDA Rule on Laboratory-Developed Tests
WASHINGTON, D.C. – Today, AdvaMed, the Medtech Association, released the following statements from President and CEO Scott Whitaker and Zach Rothstein, Executive Director of AdvaMedDx, on FDA’s final rule for Laboratory Developed Tests (LDTs): “We appreciate FDA’s commitment to ensuring the safety and effectiveness of in vitro diagnostic tests, regardless of their source, which is what today’s rule…
Read MoreClinicalMind Acquires 11TEN Innovation Partners, Uniting Cutting-Edge Medical Communications with Strategic Consulting to Drive Innovation in Life Sciences
NEW YORK, April 23, 2024 /PRNewswire-PRWeb/ — ClinicalMind, LLC (CM), a premier healthcare marketing and communications company, today announced the acquisition of 11TEN Innovation Partners (11TEN), a leading strategy consulting firm with a robust healthcare innovation ecosystem. This strategic move combines CM’s expertise in medical communications and training with 11TEN’s capabilities in commercial strategy and innovation consulting,…
Read MoreCoreRx strikes $130M deal to snap up struggling small-molecule specialist Societal CDMO
Several months after Societal CDMO launched a restructuring campaign that led to 26 layoffs, the small molecule contract manufacturer has announced it’s being bought by one of its production peers in Florida. Privately held manufacturer CoreRx has entered a definitive agreement to purchase Societal for $1.10 per share in cash, leading to a total deal…
Read MorePONIX AWARDED $5 MILLION USDA GRANTTO BREAK “GROUND” ON CLIMATE-SMART AGRICULTURE IN GEORGIA
Through USDA’s Partnerships for Climate-Smart Commodities Program, the Initiative isRecruiting 24 Minority and Underserved Georgia Farmers to Adopt Hydroponic Farming ATLANTA (April 22, 2024) – The Coalition of Food Security (CFS), led byminority-owned AgTech start-up, Ponix, is implementing a $5 million United StatesDepartment of Agriculture (USDA) grant, as part of the Partnerships for Climate-SmartCommodities program,…
Read MoreAnnoviant™ Awarded $2.99 Million NIH Grant to Advance TxGuard™ Pulmonary-Valved Conduit for Pediatric Heart Disease
Funding represents a significant step forward in Annoviant’s mission to transform the landscape of pediatric cardiac care. Atlanta, April 16, 2024 – Annoviant™, Inc., a pioneering company with a breakthrough TxGuardTM technology platform for soft-tissue healing, currently focused on cardiovascular field, proudly announces receipt of a $2.99 million grant (SBIR Phase 2b) from the National Institutes of Health (NIH). This grant aims to propel the development and commercialization of its revolutionary TxGuard™…
Read MoreA Letter from GCMI Interim Executive Director Saylan Lukas – GCMI’s Continuing Commitment to Excellence in Medtech Innovation
Medtech and life science innovation is rigorous. It requires high levels of acumen and proficiency in multiple disciplines. It can also be immensely capital intensive. Tiffany Wilson founded Atlanta’s Global Center for Medical Innovation (GCMI) in 2012 to help medtech innovators de-risk their technologies, increasing their odds of successful commercialization and positive patient outcomes within…
Read MoreGeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
Atlanta, GA, January 29, 2024 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that the Company’s Board of Directors has approved a reverse stock split of its issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”), at a…
Read More